Testosterone in men declines at a rate of around 1% a year from age 30. That doesn’t mean that men go through the ‘manopause’.
A group of academics look at the global evidence to examine the potential impact of safe injection sites in Philadelphia and the US.
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Walmart is going to give all of its...
A group of academics look at the global evidence to examine the potential impact of safe injection sites in Philadelphia and the US.
The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to four researchers from the Texas Tech University Health Sciences...
Data from a year-long Phase I clinical trial suggest that a donor regulatory dendritic cell therapy for people who are receiving liver transplants can...
Credit: Vall d’Hebron Institute of Oncology (VHIO). Developed by VHIO investigators, VIGex is a gene expression signature that classifies solid tumors...
Investors Alley The Weight Loss Drug Gold Mine On September 27, the healthcare data analytics firm Trilliant Health released a blockbuster report on the...
In releasing second-quarter results in August, Prime Medicine conveyed the possibility of a first trial for its gene editing technology next year by publicly...
Pharma marketers are spending more money and time targeting retail pharmacies — and their video displays, mobile phone alerts and even refrigerator doors...
Positron, the antiparticle of electron, has the same mass and charge as that of an electron but with the sign flipped for the charge. It is...
Moms Shine Spotlight On Harms Caused By Youth Transgender Movement Authored by Emel Akan via The Epoch Times (emphasis ours), The transgender...
The Dangers Of Investigating Big Pharma Commentary by Jeffrey A. Tucker via The Epoch Times (emphasis ours), My family is from Texas (since...
Patients with X-linked severe combined immunodeficiency disorder (SCID-X1), sometimes called “bubble boy disease,” are born with a defective gene that...
“Several ongoing trials hope to further elucidate the role of lurbinectedin in highgrade neuroendocrine neoplasms […]” Credit: 2023 Bhamidipati and...
Cancer cells are chameleons. They completely change their metabolism to grow continuously. University of Basel scientists have discovered that high levels...
Libmeldy® (atidarsagene autotemcel) is indicated for patients with early-onset metachromatic leukodystrophy (MLD). Libmeldy is approved by the European...
Gene therapies, antibody fragments, and microRNA drug products are being developed to counter cardiovascular disease mechanisms The post New Drugs May...
Atomwise entered a new phase of its journey as a company this week with the nomination of its first AI-driven development candidate, a small molecule focused...
After stepping into the CEO post for the first time about two years ago, taking over the helm of “tissue therapeutics” startup Satellite Bio, Dave...
Orchard Therapeutics (NASDAQ: ORTX) experienced a remarkable 97% surge in its shares following a major announcement on October 5th, 2023. The renowned...
Atsena Therapeutics has reduced its staff, is looking for a partner and has reeled in more cash from existing investors, the gene therapy biotech told...
The newest approved opioid use disorder drug is leaning on its flexible dosing schedule and injection site convenience to gain traction. Braeburn’s Brixadi...
Gavin Newsom made a bold maneuver in the realm of psychedelic medicine recently. The Democrat Governor signed a groundbreaking law authorizing medical...
Sponsored content brought to you by In 2023, the number of FDA-approved cell and gene therapies is poised to increase by more than 50%. As the...
Sponsored content brought to you by By Jay AA West, PhD There is a revolution taking place in the field of genomics. Next-generation sequencing (NGS)...
Philadelphia, October 5, 2023 – Reproductive endocrinology and infertility (REI) has finally come of age, moving beyond the “basics,” limited accessibility,...
With our faces seemingly everywhere − from Zoom meetings to selfies − more people are developing anxieties about how they appear online.
US and Dutch gene therapy maker uniQure will undergo a broad overhaul that sees 20% of its workforce laid off, the departure of its chief scientific...
US and Dutch gene therapy maker uniQure will undergo a broad overhaul that sees 20% of its workforce laid off, the departure of its chief scientific...